"description","label","text","instanceType","name","id","uuid:ID"
"Main objective","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective","OBJ1","Objective_1","7215185a-34f1-44a5-9afd-66344b6e81e8"
"Safety","","To document the safety profile of the xanomeline TTS.","Objective","OBJ2","Objective_2","254a9e98-3f27-476b-bcc7-2f6883e272af"
"Behaviour","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective","OBJ3","Objective_3","822bd63b-3062-482f-8ce7-1d58cba59cb9"
